Table 4.
Association between serum anti-oxLDL titres and CVD risk factors in stepwise multiple regression analysis.
| Covariate | β | P | 95% confidence interval |
|---|---|---|---|
| Age | −.162 | .616 | −.096–0.60 |
| FBS | .402 | .290 | −.007–0.020 |
| LDL-C | .090 | .759 | −.021–0.028 |
| HDL-C | −.290 | .349 | −.085–0.034 |
| TG | .005 | .990 | −.016–0.016 |
| SBP | .136 | .693 | −.022–0.031 |
| DBP | −.388 | .389 | −.099–0.043 |
| DM | .227 | .546 | −1.676–2.938 |
| Smoking | .105 | .699 | −.482–0.684 |
| HTN | .360 | .275 | −.720–2.210 |
| HLP | −.123 | .592 | −1.337–0.815 |
| BMI | −.651 | .615 | −.599–0.378 |
| Waist hip ratio | −2.085 | .430 | −105.209–49.503 |
FBS: fasting blood sugar; BMI: body mass index; LDL-C: low-density lipoprotein cholesterol; HDL-C: high-density lipoprotein cholesterol; TG: triglycerides; SBP: systolic blood pressure; DBP: diastolic blood pressure; HTN: hypertension; HLP: hyperlipidemia; BMI: body mass index.